PLUS THERAPEUTICS (PSTV) Peer Comparison

$3.84

$0.07 (1.80%)

As on 07-Aug-2026 09:30EDT

Market cap

$27 Mln

Revenue (TTM)

$4 Mln

P/E Ratio

0.2

P/B Ratio

4.3

Div. Yield

0 %

Edit

	PLUS THERAPEUTICS (PSTV)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Market cap ($ Mln)	27	16,765	16,261	13,492	11,994
Revenue ($ Mln)	4	2,782	1,054	2,436	670
Net Profit ($ Mln)	-26.09	491.50	755.85	860.62	-319.95
Net Margin (%)	-620.70	17.67	71.69	35.33	-47.79
RoE (%)	-551.60	110.09	--	42.98	-71.14
Price to Earnings	0.18	35.25	19.00	17.40	--
Price-To-Book	4.31	39.29	9.76	7.42	26.87

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	PLUS THERAPEUTICS (PSTV)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Operating Revenue	4.20	2,782.29	1,054.37	2,435.92	669.50
Cost of Revenue	0.40	1,982.07	103.47	85.67	19.14
Gross Profit	4.77	760.62	588.53	2,236.43	829.45
Operating Expenses	30.32	216.81	841.45	1,378.74	895.93
Operating Profit (EBIT)	-26.40	583.40	109.45	971.51	-226.44
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-26.09	598.92	101.11	1,035.47	-252.08
Provision for Tax	0.00	107.42	-654.74	174.84	20.05
Profit after Tax (Net Income)	-26.09	491.50	755.85	860.62	-319.95
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Consolidated Profit	0.00	0.00	0.00	0.00	0.00

Liabilities ($ Mln)

	PLUS THERAPEUTICS (PSTV)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Shareholder's Funds	5.46	433.86	1,435.90	1,843.76	465.53
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Non-Current Liabilities	0.00	187.89	384.48	288.55	1,362.63
Current Liabilities	8.57	1,435.43	464.70	361.93	283.35
Total Liabilities	16.33	1,975.47	1,302.02	2,844.42	1,385.30

Assets ($ Mln)

	PLUS THERAPEUTICS (PSTV)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Non-Current Assets	2.26	1,006.90	895.24	1,243.41	440.60
Current Assets	11.77	1,050.29	1,389.84	1,250.82	1,671.41
Total Assets	16.33	1,975.47	1,302.02	2,844.42	1,385.30
Total Debt*	0.04	120.10	449.89	165.93	864.07
Net Current Assets	0.00	-385.14	0.00	888.90	1,388.07

Cashflow ($ Mln)

	PLUS THERAPEUTICS (PSTV)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Cash From Operating Activities	-20.78	713.22	51.77	884.27	179.55
Cash Flow from Investing Activities	-0.85	-31.14	-8.15	350.44	-129.29
Cash from Financing Activities	30.31	-860.39	34.89	-969.59	74.01
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	PLUS THERAPEUTICS (PSTV)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
ROCE (%)	5,852.55	53.56	-30.01	32.82	-0.17
ROE (%)	-551.60	110.09	163.18	42.98	-71.14
ROA (%)	-120.04	15.64	26.53	29.32	-16.12
EBIT Margin (%)	-539.71	21.13	5.73	31.04	-0.77
Net Margin (%)	-620.70	17.67	71.69	35.33	-47.79
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	PLUS THERAPEUTICS (PSTV)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Revenue Growth (%)	-20.95	24.67	114.85	9.23	12.22
EBIT Growth (%)	-49.73	18.70	136.39	-3.99	93.17
Net Profit Growth (%)	-37.11	17.50	378.76	42.89	-115.58
EPS Growth (%)	-91.77	26.84	353.27	50.42	-73.87
Book Value Growth (%)	5,460.27	164.02	816.12	-0.70	-13.57

Valuation Ratios

	PLUS THERAPEUTICS (PSTV)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Price / Earnings	-0.07	36.06	-59.76	15.79	-2,869.63
Price / Book Value	0.40	39.29	9.76	7.42	26.87
Dividend Yield (%)	--	0.00	0.00	0.00	0.00
EV/EBITDA	0.58	27.43	211.41	12.12	-81.53
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	PLUS THERAPEUTICS (PSTV)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debt to Equity	0.00	0.00	0.00	0.00	1.77
Short term debt to equity ratio	0.01	0.00	0.05	0.00	0.09
Current Ratio	1.37	0.73	2.99	3.46	5.90
Quick Ratio	1.37	0.73	2.32	3.38	5.90
Interest Coverage	-7.46	--	1.62	--	-1.72

Operating Efficiency Ratios

	PLUS THERAPEUTICS (PSTV)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debtors to sales (%)	41.90	15.88	21.25	13.74	1.28
Asset Turnover	0.19	0.89	0.37	0.83	0.34
Receivable days	40.01	50.42	85.52	43.48	1.50
Inventory Days	--	--	1,056.70	96.17	--
Payable days	5,232.51	6.26	331.01	147.97	221.81
Cash Conversion Cycle	--	--	811.21	-8.32	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly